Deadline: 21-Apr-22
The European Commission (EC) is pleased to announce a call for proposals for the European Partnership Fostering European Research Area (ERA) for Health Research.
The “ERA for Health” Partnership will be a leading European initiative for the flexible joint programming of health related research and innovation programmes, effectively involving a wide variety of European funding organisations.
This Partnership will be open in particular to public funders of Health research at both national and regional level in the Member States, countries associated to Horizon Europe and to other funders such as philanthropic organisations. Special attention will be placed on engaging with and including many research funders with relatively small budgets.
Phases
The Partnership will integrate research and innovation areas covered by previous ERANET co-fund actions, Joint Programming Initiatives (JPIs), as well as IICSs. It will be composed of two phases.
- Phase 1 will integrate European initiatives selected as most relevant by the partners and initially implement joint calls on nutrition- and lifestyle-related diseases, cardiovascular diseases and nano-medicine. In parallel, it will test the possibility to carry out joint calls for proposals for R&I activities on IICSs. Phase 1 will last for 2 years. After this period, the Horizon Europe Health Programme Committee will decide whether to extend and intensify the focus on IICSs. This decision will be based on objective criteria to be specified in the final proposals. They will only affect the focus area and budget of the partnership, not its existence over the 7 years.
- During Phase 2, additional multinational calls for IICSs and joint calls for other priority areas will be launched in accordance with the decision of the Health Programme Committee taken at the end of Phase 1 on the focus of the Partnership and the distribution of the budget between IICSs and other areas.
Funding Information
The check will normally be done for the coordinator if the requested grant amount is equal to or greater than EUR 500 000, except for:
- public bodies (entities established as a public body under national law, including local, regional or national authorities) or international organisations; and
- cases where the individual requested grant amount is not more than EUR 60 000 (lowvalue grant).
Outcomes
Proposals under this topic should aim for delivering results that are contributing to all of the following expected outcomes:
- Based on a trusted governance and effective working modalities, research funders, health policy-makers and the research community work together in order to identify and prioritise topics of common interest and European benefit;
- Research funders and policy-makers:
- support the generation of knowledge related, but not limited, to cardiovascular diseases, diet related diseases and nano medical technologies, and have access to and make use of the evidence on the benefits and drawbacks of health interventions, in particular for optimising clinical management, personalised medicine (coordinating with the future Partnership on Personalised Medicine) and avoiding overtreatment;
- overcome the main obstacles to test health interventions at European level. Therefore, the research community, independently from private interest, can conduct large-scale Investigator-Initiated Clinical Studies (IICSs) of various health interventions addressing important public health needs in a seamless way, effectively addressing known challenges related to, for example, appropriate study design, ethics (including special patient groups), regulatory and institutional approvals, patient recruitment, management of informed consent, as well as, bio banking of human samples;
- Public health research systems in the ERA are more effective and integrated. Utilization of health services, preventative measures, technologies, tools and digital solutions are more cost-effective;
- Health and care authorities, policymakers and other stakeholders use the research results to develop evidence-based strategies and policies, and deploy good practices to European countries and regions;
- Patients and citizens are more knowledgeable about disease threats and contribute to a patient-centred decision-making process, assuring better adherence to knowledge-based disease management strategies and policies (including for controlling outbreaks and emergencies);
- Countries cooperate better and use context-specific knowledge and evidence to make their health and care systems more sustainable and resilient with respect to upcoming needs and crises (Complementary with the Co-Funded Partnership on Transforming Health and Care Systems with which strong links will be established).
Eligibility Criteria
To be eligible for funding, applicants must be established in one of the eligible countries, i.e.:
- the Member States of the European Union, including their outermost regions;
- the Overseas Countries and Territories (OCTs) linked to the Member States;
- eligible non-EU countries:
- countries associated to Horizon Europe
- low- and middle-income countries.
For more information, visit https://bit.ly/31XYFnx
